Pooled results demonstrated that a high serum PSA was significantly associated with a poor OS and progression-free survival (in a manner similar to PSA).[11] Heinrich et al[12] also recently reassessed the current role and possible value of ALP in patients with metastatic castrate-resistant prostate cancer in the setting of various available treatment modalities. The gene discussed is KLK3; the disease is prostate carcinoma.